Document is current
Any future updates will be listed below
-
Authors
Chernonosova, Vera https://orcid.org/0000-0001-5647-5169
Wenhui, Yu
Skorokhodova, Ekaterina
Golyshev, Victor https://orcid.org/0000-0002-0521-6228
Shefer, Aleksei https://orcid.org/0000-0001-5369-397X
Laktionov, Pavel https://orcid.org/0000-0002-0866-0252
-
Funding
Funding for this research was provided by:
Russian state-funded project for ICBFM SB RAS (125012300656-5)
Russian state-funded project for ICBFM SB RAS (125012300656-5)
Russian state-funded project for ICBFM SB RAS (125012300656-5)
- License Information
-
More Information
Article History
Received: 28 October 2025
Accepted: 30 January 2026
First Online: 16 February 2026
Declarations
: The use of the commercially available EA.hy926 cell line and human gingival fibroblasts provided by Dr. Cherepanova A. in this study was reviewed and approved by the Ethics Committee of the ICBFM SB RAS (Protocol No. 1, 15 January 2016).
: The authors declare no competing interests.
